| NCT ID | NCT06682494 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Oral Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-09-24 |
| Primary Completion | 2027-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-09-24 with a primary completion date of 2027-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the impact of AI-powered chatbot interactions versus traditional educational handouts on increasing participants' knowledge of oral cancer and its prevention
Eligibility Criteria
Inclusion Criteria: * Identify as African American as defined by the US Census * Participants must be able to read, speak, and write in English Exclusion Criteria: * Individuals who cannot physically or mentally participate in the research project will be excluded * Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Prisoners
Contact & Investigator
Tamas Gal, Ph.D
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT06682494 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oral Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06682494 currently recruiting?
Yes, NCT06682494 is actively recruiting participants. Contact the research team at Tamas.Gal@vcuhealth.org for enrollment information.
Where is the NCT06682494 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT06682494 clinical trial?
NCT06682494 is sponsored by Virginia Commonwealth University. The principal investigator is Tamas Gal, Ph.D at Virginia Commonwealth University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.